61 results on '"Henry-Amar, M."'
Search Results
2. OC-0060: Cardiac risk prediction: Moving beyond a mean heart dose model?
3. Clinical achievements of the EORTC Lymphoma Group and aspects of future group strategy
4. 6017 POSTER DISCUSSION Quality of Life and Reintegration of Long-Term Survivors of Colorectal Cancer: a Population-Based Study
5. Qualité de vie et réinsertion des patients considérés guéris d’un cancer colorectal : étude à partir de registres de population
6. Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: A French multicenter phase II study
7. Qualité de vie à long terme après un cancer du sein en France
8. Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials
9. Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity
10. O-040 Randomized phase III trial for stage III unresectable nonsmall cell lung (NSCLC) cancer: Induction Chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)] followed by conventional radiation (RT) without (arm A) or with daily carboplatin (Cb) (arm B). Final results. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT
11. P3-3 Investigation d’une suspicion d’agrégat de leucémie dans la zone de gaillon (Eure)
12. 874 Ir192 conformal brachytherapy and external beam radiation (EBR-CU.ir192) with or without hormonotherapy for locally advanced prostate adenocarcinoma: the centre françois baclesse experience
13. Densité minérale osseuse et marqueurs biologiques de remaniement osseux chez des patients porteurs d’incidentalome surrénalien : effet d’un hypercortisolisme infraclinique
14. The achievements of the EORTC Lymphoma Group
15. Involved-field radiotherapy in patients with stage III/IV Hodgkin’s lymphoma: first results of the randomised EORTC trial # 20884
16. Navelbine (NVB)-cisplatin (CDDP) induction chemotherapy (ICT) followed by radiation with or without daily carboplatin (CBDCA) in locally advanced unresectable non small cell lung cancer: Intermediate analysis of a french, multicenter phase III randomized trial
17. 72 Low dose (LDR) or high dose (HDR) rate IR-192 conformal brachytherapy with temporary transperineal implantation in combination with external beam radiation (EBR) for non-metastatic prostate adenocarcinoma: The centre françois baclesse experience in 531 cases treated between July 1987 and December 1997
18. Guérir la maladie de Hodgkin, et après ?
19. Le rôle de la radiothérapie dans les formes localisées de maladie de Hodgkin en 1999: limitations et perspectives
20. DNA damaging effects of pesticides measured by the single cell gel electrophoresis assay (comet assay) and the chromosomal aberration test, in CHOK1 cells
21. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer
22. Traitement de l'adénocarcinome prostatique par association radiothérapie-curiethéraphie
23. Quality of life assessment in Hodgkin’s disease: A new comprehensive approach
24. P48 Le traitement des adénocarcinomes de l'endomètre. À propos d'une analyse rétrospective de 445 cas traités au centre François-Baclesse de Caen de 1980 à 1990
25. P XVI A.12 Use of alkaline comet assay to detect DNA damages in mononuclear leukocytes of farmers occupationally exposed to pesticides
26. Health-related quality of life and sequelae in patients treated with external beam irradiation (EBI) and brachytherapy for localized prostate cancer (LPC)
27. 352 Induction chemotherapy (ICT cisplatin and vinorelbine) followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): Final analysis of a phase II trial
28. 354 Efficacy of induction chemotherapy (ICT) before concomitant chemoradiotherapy (CRCT) is predictive of local control and survival in unresectable locally advanced non small cell lung cancer (NSCLC)
29. Assessment of DNA damage induced in vitro by etoposide and two fungicides (carbendazim and chlorothalonil) in human lymphocytes with the comet assay
30. Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: Interim results from the ongoing EORTC-LCG and GPMC phase III trial
31. 77 Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I–II Hodgkin's disease six-year results of the EORTC-GPMC controlled clinical trials ‘H7-VF’, ‘H7-F’ and ‘H7-U’
32. Combined modality treatment for poor prognosis stages I and II Hodgkin's disease
33. 8 Combined external beam therapy (EBT) and brachytherapy in the treatment of localized prostate carcinoma: The 1979–1993 Centre Franc¸ois Baclesse experience
34. 2139 Chemotherapy followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): First interim analysis of a phase II trial
35. P45 La curiethérapie vaginale dans les cancers de l'endomètre au CFB
36. Late complications after Hodgkin's disease
37. 790 Rehabilitation of long-term survivors after Hodgkin's disease: A cross-sectional study in Calvados, France
38. Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis?
39. Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation
40. Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease
41. Follow-up thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease an up-date
42. Linitis plastica after Hodgkin's disease
43. Follow-up thallium-201 scintigraphy after mantle field radiotherapy for hodgkin's disease
44. Workshop I: Review on prognostic factors
45. International Database on Hodgkin's Disease: A cooperative effort to determine treatment outcome
46. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease
47. The EORTC trials for limited stage Hodgkin's disease
48. Pericarditis and myocardial infarctions after Hodgkin's disease therapy
49. Management of relapse and survival in advanced stage Hodgkin's disease: The EORTC experience
50. Long-term toxicity of early stages of Hodgkin's disease therapy: The EORTC experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.